ANDA 74751, held by Watson Labs. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 74751 (Clomipramine Hydrochloride), held by Watson Labs, was first approved by FDA on Sep 30, 1998, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 30, 1998 | Original application | Approved |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters